Tragedy in Shanghai Sparks Debate on Gene-Editing Ethics
A six-year-old girl's death in a Shanghai clinical trial for gene-editing treatment has ignited global debate over ethical standards in biotechnology. The trial, aiming to treat a neurodevelopmental syndrome, underscores the urgent need for regulatory oversight in China's burgeoning biotech …
Read more →
